has sponsored live events, journal education, and internet-based CME activities and has awarded more than 80,000 hours of CME credit.
Early View from The Oncologist
- Real‐World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer
- Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor–Positive Metastatic Breast Cancer
- Eflapegrastim, a Long‐Acting Granulocyte‐Colony Stimulating Factor for the Management of Chemotherapy‐Induced Neutropenia: Results of a Phase III Trial
- Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial
- Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer
- Early and Late Recurrence of Hepatitis B Virus–Associated Hepatocellular Carcinoma
- The Clinical Significance of Neuroendocrine Features in Invasive Breast Carcinomas
- Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single‐Arm, Open‐Label, Phase II Study
- Accrual, Publication Bias, and the Coronavirus in 2020
- Cervical Cancer in Young Women: Do They Have a Worse Prognosis? A Retrospective Cohort Analysis in a Population of Mexico